{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:45:51Z","timestamp":1788543951608,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s12185-025-03928-y","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T10:00:55Z","timestamp":1739613655000},"page":"586-591","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024: significance of guidelines developed for each underlying disease"],"prefix":"10.1007","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1834-1690","authenticated-orcid":false,"given":"Hidesaku","family":"Asakura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,15]]},"reference":[{"key":"3928_CR1","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1056\/NEJM199908193410807","volume":"341","author":"M Levi","year":"1999","unstructured":"Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med. 1999;341:586\u201392.","journal-title":"N Engl J Med"},{"key":"3928_CR2","doi-asserted-by":"publisher","first-page":"16037","DOI":"10.1038\/nrdp.2016.37","volume":"2","author":"S Gando","year":"2016","unstructured":"Gando S, Levi M, Toh CH. Disseminated intravascular coagulation. Nat Rev Dis Primers. 2016;2:16037.","journal-title":"Nat Rev Dis Primers"},{"key":"3928_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2052-0492-2-15","volume":"2","author":"H Wada","year":"2014","unstructured":"Wada H, Matsumoto T, Yamashita Y. Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines. J Intensive Care. 2014;2:15.","journal-title":"J Intensive Care"},{"key":"3928_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40560-023-00672-5","volume":"11","author":"T Iba","year":"2023","unstructured":"Iba T, Helms J, Connors JM, Levy JH. The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation. J Intensive Care. 2023;11:24.","journal-title":"J Intensive Care"},{"key":"3928_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12185-020-03030-5","volume":"113","author":"H Asakura","year":"2021","unstructured":"Asakura H. Diversity of disseminated intravascular coagulation and selection of appropriate treatments. Int J Hematol. 2021;113:10\u20134.","journal-title":"Int J Hematol"},{"key":"3928_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/2052-0492-2-20","volume":"2","author":"H Asakura","year":"2014","unstructured":"Asakura H. Classifying types of disseminated intravascular coagulation: clinical and animal models. J Intensive Care. 2014;2:20.","journal-title":"J Intensive Care"},{"key":"3928_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12185-020-02992-w","volume":"113","author":"T Ikezoe","year":"2021","unstructured":"Ikezoe T. Advances in the diagnosis and treatment of disseminated intravascular coagulation in hematological malignancies. Int J Hematol. 2021;113:34\u201344.","journal-title":"Int J Hematol"},{"key":"3928_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12959-016-0117-x","volume":"14","author":"H Asakura","year":"2016","unstructured":"Asakura H, Takahashi H, Uchiyama T, Eguchi Y, Okamoto K, Kawasugi K, et al. Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J. 2016;14:42.","journal-title":"Thromb J"},{"key":"3928_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12959-017-0142-4","volume":"15","author":"H Wada","year":"2017","unstructured":"Wada H, Takahashi H, Uchiyama T, Eguchi Y, Okamoto K, Kawasugi K, et al. The approval of revised diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J. 2017;15:17.","journal-title":"Thromb J"},{"key":"3928_CR10","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.3390\/ijms23031296","volume":"23","author":"S Yamada","year":"2022","unstructured":"Yamada S, Asakura H. Therapeutic strategies for disseminated intravascular coagulation associated with aortic aneurysm. Int J Mol Sci. 2022;23:1296.","journal-title":"Int J Mol Sci"},{"key":"3928_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12185-020-03028-z","volume":"113","author":"S Yamada","year":"2021","unstructured":"Yamada S, Asakura H. Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations. Int J Hematol. 2021;113:15\u201323.","journal-title":"Int J Hematol"},{"key":"3928_CR12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.thromres.2008.03.027","volume":"123","author":"T Hayashi","year":"2008","unstructured":"Hayashi T, Morishita E, Ohtake H, Oda Y, Ohta K, Arahata M, et al. Expression of annexin II in human atherosclerotic abdominal aortic aneurysms. Thromb Res. 2008;123:274\u201380.","journal-title":"Thromb Res"},{"key":"3928_CR13","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1055\/s-0037-1616068","volume":"86","author":"FB Taylor Jr","year":"2001","unstructured":"Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M, Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327\u201330.","journal-title":"Thromb Haemost"},{"key":"3928_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/ajh.2830330204","volume":"33","author":"H Takahashi","year":"1990","unstructured":"Takahashi H, Tatewaki W, Wada K, Hanano M, Shibata A. Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders. Am J Hematol. 1990;33:90\u20135.","journal-title":"Am J Hematol"},{"key":"3928_CR15","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/00001721-199410000-00022","volume":"5","author":"H Asakura","year":"1994","unstructured":"Asakura H, Jokaji H, Saito M, Uotani C, Kumabashiri I, Morishita E, et al. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers. Blood Coagul Fibrinolysis. 1994;5:829\u201332.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"3928_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12185-020-03029-y","volume":"113","author":"H Asakura","year":"2021","unstructured":"Asakura H, Ogawa H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int J Hematol. 2021;113:45\u201357.","journal-title":"Int J Hematol"},{"issue":"12","key":"3928_CR17","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1016\/S2213-2600(20)30467-7","volume":"8","author":"H Asakura","year":"2020","unstructured":"Asakura H, Ogawa H. Overcoming bleeding events related to extracorporeal membrane oxygenation in COVID-19. Lancet Respir Med. 2020;8(12):e87\u20138.","journal-title":"Lancet Respir Med"},{"key":"3928_CR18","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.2169\/internalmedicine.7697-21","volume":"61","author":"E Takada","year":"2022","unstructured":"Takada E, Adachi S, Horibe Y, Shimizu M. Intramuscular bleeding triggered by disseminated intravascular coagulation with enhanced fibrinolysis in a patient with prostate cancer. Intern Med. 2022;61:1411\u20133.","journal-title":"Intern Med"},{"key":"3928_CR19","doi-asserted-by":"publisher","first-page":"e1251","DOI":"10.1097\/CCM.0000000000004665","volume":"48","author":"T Oda","year":"2020","unstructured":"Oda T, Tamura N, Ide R, Itoh T, Horikoshi Y, Matsumoto M, et al. Consumptive coagulopathy involving amniotic fluid embolism: The importance of earlier assessments for interventions in critical care. Crit Care Med. 2020;48:e1251\u20139.","journal-title":"Crit Care Med"},{"key":"3928_CR20","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1111\/jth.14931","volume":"18","author":"S Gando","year":"2020","unstructured":"Gando S, Shiraishi A, Wada T, Yamakawa K, Fujishima S, Saitoh D, et al. A multicenter prospective validation study on disseminated intravascular coagulation in trauma-induced coagulopathy. J Thromb Haemost. 2020;18:2232\u201344.","journal-title":"J Thromb Haemost"},{"key":"3928_CR21","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.3390\/ijms23063338","volume":"23","author":"S Yamada","year":"2022","unstructured":"Yamada S, Asakura H. Coagulopathy and fibrinolytic pathophysiology in COVID-19 and SARS-CoV-2 vaccination. Int J Mol Sci. 2022;23:3338.","journal-title":"Int J Mol Sci"},{"key":"3928_CR22","first-page":"265","volume":"49","author":"N Kobayashi","year":"1983","unstructured":"Kobayashi N, Maekawa T, Takada M, Tanaka H, Gonmori H. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl Haematol. 1983;49:265\u201375.","journal-title":"Bibl Haematol"},{"key":"3928_CR23","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/01.CCM.0000202209.42491.38","volume":"34","author":"S Gando","year":"2006","unstructured":"Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med. 2006;34:625\u201331.","journal-title":"Crit Care Med"},{"key":"3928_CR24","doi-asserted-by":"publisher","first-page":"R297","DOI":"10.1186\/cc13163","volume":"17","author":"S Gando","year":"2013","unstructured":"Gando S, Saitoh D, Ishikura H, Ueyama M, Otomo Y, Oda S, et al. A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis. Crit Care. 2013;17:R297.","journal-title":"Crit Care"},{"key":"3928_CR25","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/0049-3848(88)90349-0","volume":"50","author":"H Asakura","year":"1988","unstructured":"Asakura H, Saito M, Ito K, Jokaji Y, Uotani C, Kumabashiri I, et al. Levels of thrombin-antithrombin III complex in plasma in cases of acute promyelocytic leukemia. Thromb Res. 1988;50:895\u20139.","journal-title":"Thromb Res"},{"key":"3928_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1538-7836.2006.02267.x","volume":"5","author":"H Saito","year":"2007","unstructured":"Saito H, Maruyama I, Shimazaki S, Yamamoto Y, Aikawa N, Ohno R, et al. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: Results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost. 2007;5:31\u201341.","journal-title":"J Thromb Haemost"},{"key":"3928_CR27","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13054-019-2552-0","volume":"23","author":"T Ito","year":"2019","unstructured":"Ito T, Thachil J, Asakura H, Levy JH, Iba T. Thrombomodulin in disseminated intravascular coagulation and other critical conditions\u2014a multi-faceted anticoagulant protein with therapeutic potential. Crit Care. 2019;23:280.","journal-title":"Crit Care"},{"key":"3928_CR28","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.thromres.2013.12.033","volume":"133","author":"H Asakura","year":"2014","unstructured":"Asakura H, Takahashi H, Tsuji H, Matsushita T, Ninomiya H, Honda G, et al. Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation\u2014safety and efficacy in 1032 patients with hematologic malignancy. Thromb Res. 2014;133:364\u201370.","journal-title":"Thromb Res"},{"key":"3928_CR29","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s10147-014-0768-1","volume":"20","author":"K Tamura","year":"2015","unstructured":"Tamura K, Saito H, Asakura H, Okamoto K, Tagawa J, Hayakawa T, et al. Recombinant human soluble thrombomodulin (thrombomodulin alfa) to treat disseminated intravascular coagulation in solid tumors: Results of a one-arm prospective trial. Int J Clin Oncol. 2015;20:821\u20138.","journal-title":"Int J Clin Oncol"},{"key":"3928_CR30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13613-017-0332-z","volume":"7","author":"T Iba","year":"2017","unstructured":"Iba T, Hagiwara A, Saitoh D, Anan H, Ueki Y, Sato K, et al. Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation. Ann Intensive Care. 2017;7:110.","journal-title":"Ann Intensive Care"},{"key":"3928_CR31","doi-asserted-by":"publisher","first-page":"107602962210770","DOI":"10.1177\/10760296221077096","volume":"28","author":"A Murao","year":"2022","unstructured":"Murao A, Kato T, Yamane T, Honda G, Eguchi Y. Benefit profile of thrombomodulin alfa combined with antithrombin concentrate in patients with sepsis-induced disseminated intravascular coagulation. Clin Appl Thromb Hemost. 2022;28:10760296221077096.","journal-title":"Clin Appl Thromb Hemost"},{"key":"3928_CR32","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1182\/blood.V19.6.694.694","volume":"19","author":"RL Naeye","year":"1962","unstructured":"Naeye RL. Thrombotic state after a hemorrhagic diathesis, a possible complication of therapy with epsilon-aminocaproic acid. Blood. 1962;19:694\u2013701.","journal-title":"Blood"},{"key":"3928_CR33","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1056\/NEJM196905152802006","volume":"280","author":"C Charytan","year":"1969","unstructured":"Charytan C, Purtilo D. Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy. N Engl J Med. 1969;280:1102\u20134.","journal-title":"N Engl J Med"},{"key":"3928_CR34","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1253\/circj.69.1150","volume":"69","author":"Y Ontachi","year":"2005","unstructured":"Ontachi Y, Asakura H, Arahata M, Kadohira Y, Maekawa M, Hayashi T, et al. Effect of combined therapy of danaparoid sodium and tranexamic acid on chronic disseminated intravascular coagulation associated with abdominal aortic aneurysm. Circ J. 2005;69:1150\u20133.","journal-title":"Circ J"},{"key":"3928_CR35","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3400\/avd.cr.20-00148","volume":"14","author":"S Yamada","year":"2021","unstructured":"Yamada S, Arahata M, Morishita E, Asakura H. Blue rubber bleb nevus syndrome complicated by enhanced-fibrinolytic-type DIC: A case report. Ann Vasc Dis. 2021;14:252\u20135.","journal-title":"Ann Vasc Dis"},{"key":"3928_CR36","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1089\/jpm.2022.0249","volume":"26","author":"S Yamada","year":"2023","unstructured":"Yamada S, Suga Y, Morishita E, Asakura H. Effect of anticoagulant\/antifibrinolytic combination therapy on enhanced fibrinolytic-type disseminated intravascular coagulation in end-of-life stage solid tumor patients. J Palliat Med. 2023;26:307\u201311.","journal-title":"J Palliat Med"},{"key":"3928_CR37","first-page":"1113","volume":"8","author":"S Hashimoto","year":"1994","unstructured":"Hashimoto S, Koike T, Tatewaki W, Seki Y, Sato N, Azegami T, et al. Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage. Leukemia. 1994;8:1113\u20135.","journal-title":"Leukemia"},{"key":"3928_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.thromres.2021.08.014","volume":"206","author":"Y Suga","year":"2021","unstructured":"Suga Y, Tashiro K, Staub Y, Komura S, Yamada S, Morishita E, et al. Potential of continuous tPA infusion for multiple-organ failure from lipopolysaccharide-induced disseminated intravascular coagulation in rats. Thromb Res. 2021;206:84\u20137.","journal-title":"Thromb Res"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-03928-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-025-03928-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-03928-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T06:48:25Z","timestamp":1745304505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-025-03928-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3928"],"URL":"https:\/\/doi.org\/10.1007\/s12185-025-03928-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,15]]},"assertion":[{"value":"26 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Hidesaku Asakura is editor of International Journal of Hematology.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}}]}}